Xilio Therapeutics, Inc.
XLO • NASDAQ
Xilio Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Rene Russo, with a market cap of $48.1M.
Market Cap$48.1M
Employees73.0
CEORene Russo
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Xilio Therapeutics, Inc. FAQ
Common questions about Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $7.5M.
Xilio Therapeutics, Inc. has approximately 73 employees.